SCA
DXCM icon

Stuart Chaussee & Associates’s DexCom DXCM Stock Holding History

Stuart Chaussee & Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24
Closed -$1.87K – 189
2024
Q4 		$1.87K Hold
24
– – ﹤0.01% 175
2024
Q3 		$1.61K Hold
24
– – ﹤0.01% 159
2024
Q2 		$2.72K Hold
24
– – ﹤0.01% 162
2024
Q1 		$3.33K Buy
+24
New +$3.02K ﹤0.01% 153

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Stuart Chaussee & Associates's DXCM Position: Q1 2025 in Review

Stuart Chaussee & Associates sold out of DexCom (DXCM) in Q1 2025, closing a stake of 24 shares — an estimated $1.87K sold.

Stuart Chaussee & Associates first reported a position in DXCM in Q1 2024 and held it in 4 quarters. The position peaked at $3.33K in Q1 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Stuart Chaussee & Associates reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 24 DexCom shares in Q1 2025, an estimated $1.87K.
  • Stuart Chaussee & Associates first reported a position in DexCom in Q1 2024 and held it in 4 quarters.
  • Stuart Chaussee & Associates's DexCom position peaked at $3.33K in Q1 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Stuart Chaussee & Associates's 13F filing for Q1 2025, filed 16 May 2025.